CRISPR Therapeutics CRSP Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $4.57B.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CRISPR Therapeutics's market capitalization?
- CRISPR Therapeutics (CRSP) reported market capitalization of $4.57B in Q1 2026.
- How has CRISPR Therapeutics's market capitalization changed year-over-year?
- CRISPR Therapeutics's market capitalization increased by 56.4% year-over-year, from $2.92B to $4.57B.
- What is the long-term trend for CRISPR Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's market capitalization has grown at a -15.7% compound annual growth rate (CAGR), from $11.72B to $5B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.